|
|
Article: Epilepsy Rx.(Trileptal (oxcarbazepine) offered by Novartis Pharmaceuticals Corp.)(Brief Article)
- Article from:
- Family Practice News
- Article date:
- May 1, 2000
CopyrightCOPYRIGHT 2000 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Trileptal (oxcarbazepine) is indicated as adjunctive therapy or monotherapy for partial seizures in adults and as adjunctive therapy for partial seizures in children over age 4. The first antiepilepsy drug to be approved for first-line use in 5 years, Trileptal has better tolerability than ...
Related newspaper, magazine, and journal articles:
|
|
Article: NOVARTIS Pharmaceuticals Corp. and Celgene ...
Chemical Market Reporter;
October 8, 2001 ;
598 words
...NOVARTIS Pharmaceuticals Corp. and Celgene Corp. have received an FDA approvable letter for Ritalin (R) LA (methylphenidate HCI extended-release capsules) for treating attention deficit and hyperactivity disorder.
|
|